|
|
||||||||
1 Departments of Pathology and Immunology, Genentech, Incorporated, South San Francisco 94080; 3 Department of Molecular Biology, Deltagen, Incorporated, San Carlos, California 94070; and 2 Department of Pathobiology, Purdue University, West Lafayette, Indiana 47907
Tumor necrosis factor-
(TNF) is implicated as an
important proinflammatory cytokine in asthma. We evaluated mice
deficient in TNF receptor 1 (TNFR1) and TNFR2 [TNFR(
/
) mice] in a
murine model of allergic inflammation and found that TNFR(
/
) mice
had comparable or accentuated responses compared with wild-type
[TNFR(+/+)] mice. The responses were consistent among
multiple end points. Airway responsiveness after methacholine challenge
and bronchoalveolar lavage (BAL) fluid leukocyte and eosinophil
numbers in TNFR(
/
) mice were equivalent or greater than those
observed in TNFR(+/+) mice. Likewise, serum and BAL fluid IgE; lung
interleukin (IL)-2, IL-4, and IL-5 levels; and lung histological lesion
scores were comparable or greater in TNFR(
/
) mice compared with
those in TNFR(+/+) mice. TNFR(+/+) mice chronically treated with
anti-murine TNF antibody had BAL fluid leukocyte numbers and lung
lesion scores comparable to control antibody-treated mice. These
results suggest that, by itself, TNF does not have a critical
proinflammatory role in the development of allergic inflammation in
this mouse model and that the production of other cytokines associated
with allergic disease may compensate for the loss of TNF bioactivity in
the TNFR(
/
) mouse.
knockout mice; asthma; animal models; T cell subset 2 cytokines
This article has been cited by other articles:
![]() |
E. H. Walters, D. W. Reid, D. P. Johns, and C. Ward Nonpharmacological and pharmacological interventions to prevent or reduce airway remodelling Eur. Respir. J., September 1, 2007; 30(3): 574 - 588. [Abstract] [Full Text] [PDF] |
||||
![]() |
P H Howarth, K S Babu, H S Arshad, L Lau, M Buckley, W McConnell, P Beckett, M Al Ali, A Chauhan, S J Wilson, et al. Tumour necrosis factor (TNF{alpha}) as a novel therapeutic target in symptomatic corticosteroid dependent asthma Thorax, December 1, 2005; 60(12): 1012 - 1018. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Birrell, K. McCluskie, E.-B. Haddad, C. H. Battram, S. E. Webber, M. L. Foster, M. H. Yacoub, and M. G. Belvisi Pharmacological Assessment of the Nitric-Oxide Synthase Isoform Involved in Eosinophilic Inflammation in a Rat Model of Sephadex-Induced Airway Inflammation J. Pharmacol. Exp. Ther., March 1, 2003; 304(3): 1285 - 1291. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Hamada, Y. Suzaki, A. Goldman, Y. Y. Ning, C. Goldsmith, A. Palecanda, B. Coull, C. Hubeau, and L. Kobzik Allergen-Independent Maternal Transmission of Asthma Susceptibility J. Immunol., February 15, 2003; 170(4): 1683 - 1689. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Matheson, R. Lemus, R. W. Lange, M. H. Karol, and M. I. Luster Role of Tumor Necrosis Factor in Toluene Diisocyanate Asthma Am. J. Respir. Cell Mol. Biol., October 1, 2002; 27(4): 396 - 405. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |